Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak

By afschroeder • October 28, 2026

Nabukeera KC, Luakanda-Ndelemo G, Semawule S, Ayitewala A, Adroba-Tandele P, Walakira A, Amuri-Aziza A, Jansen D, Galiwango R, Kinganda-Lusamaki E, Tebba A, Ngandu C, Ssemaganda A, Tshiani-Mbaya O, Kanyerezi S, Kyokushaba J, Akil-Bandali P, Makoha C, Oundo HR, Kimbonza S, Balinandi S, Mukadi-Bamuleka D, Nakintu V, Nsio J, Mugerwa I, Kadobera D, Euriene D, Mulangu S, Ayouba A, Eliu M, Gidudu S, Kyobe Bosa H, Wayengera M, Rimoin AW, Lubwama B, Kagirita A, Ahuka-Mundeke S, Mwamba D, Kambugu A, Kaleebu P, Happi C, Liesenborghs L, Carroll MW, Maes P, Nachega JB, Peeters M, Akilimali P, Bahatungire R, Muruta A, Kindrachuk J, Rambaut A, Kyabayinze D, Olaro C, Vercauteren K, Muyembe-Tamfum JJ, Nabadda S, Atwine D, Jjingo D, Wawina-Bokalanga T, Mbala-Kingebeni P, Ssewanyana I. Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak. Nat Commun. 2026 Sep 26;17(1):11153. doi: 10.1038/s41467-026-78077-9. PMID: 42934242; PMCID: PMC13710742.

Tags: Infectious Diseases, Publications

Distinct inflammatory marker profiles of adolescents and young adults among the HIV risk, infection, and treatment spectrum

Dong HV, Salem GM, Kerin T, Tang KH, Cortado R, Shin-Sim M, Arnold EM, Swendeman D, Tobin NH, Rimoin AW, Aldrovandi GM, Yang OO, Bryson[...]

MUCOR-ADVANCE: Uniting multidisciplinary science to defeat a deadly fungus

Wurster S, Stewart AG, Gu Y, Youssef EG, John TM, Uppuluri P, Chamilos G, Filler S, Bruno V, Ibrahim AS, Kontoyiannis DP; MUCOR-ADVANCE consortium. MUCOR-ADVANCE:[...]

“We’ll Just Warm Ourselves up with Drugs”: Polysubstance Use among Sexual and Gender Minority Persons (SGMP) Who Inject Drugs in Los Angeles, California

Smeltzer RP, Orta Portillo GA, Ganesh SS, Koerber J, Gould EE, Bolanos R, Gorbach PM, Bluthenthal RN. "We'll Just Warm Ourselves up with Drugs": Polysubstance[...]